A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease (SERENITY)

Trial Details

  • 180 patients will be taking part in this study
  • Condition: Crohn's Disease
  • Intervention: Drug: Mirikizumab Drug: Placebo
  • Clinic: Care Access Research San Pablo Suite 22, 2089 Vale Road, San Pablo, CA

Summary

The purpose of this study is to evaluate the safety and effectiveness of the study drug Mirikizumab in participants with active Crohn's Disease.

Full Trial Details

Researchers

Dr. Mark Kogan

Gastroenterologist

Dr. mark kogan